期刊
CLINICAL IMMUNOLOGY
卷 122, 期 2, 页码 139-145出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2006.08.009
关键词
rituximab; B lymphocytes; transitional B cells; lymphoma
类别
资金
- NCI NIH HHS [CA-102216] Funding Source: Medline
- NIAID NIH HHS [R01 AI049660-01A1, AI56390] Funding Source: Medline
- NIAMS NIH HHS [K08AR048303] Funding Source: Medline
The long-term immunologic effects of B cell depletion with rituximab and the characteristics of the reconstituting B cell pool in lymphoma patients are not well defined, despite the widespread usage of this therapy. Here we report that during the B cell reconstitution phase a majority of the peripheral blood B cells have an immature transitional phenotype (47.8% +/- 25.2% vs. 4.4% +/- 2.4% for normal controls, p < 0.0001), similar to what has been described during the original ontogeny of the immune system and following bone marrow transplantation. Moreover, the recovery of the CD27+ memory B cell pool was delayed compared to normal B cell ontogeny, remaining below normal controls at 1 year post-rituximab (4.4% +/- 3% vs. 31% +/- 7%, p < 0.0001). Expansion of functionally immature B cells and decreased memory B cells may contribute to an immunodeficient state in patients recovering from rituximab mediated B cell depletion, particularly with repeated treatment. (c) 2006 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据